-
MEDIA RELEASE | Menzies researchers in the top 2 per cent
Menzies School of Health Research is celebrating the work of its researchers who have been ranked amongst the world’s top scientists.
-
Researchers at CDU some of the most influential in their fields
According to a Stanford University study, there were 22 academics from CDU and Menzies School of Health research who ranked in the top two per cent of researchers referenced in their respected disciplines for 2020.
-
The Australian | Hit Covid fast: antiviral drugs to keep infected out of hospital
The nation’s top doctors predict new antiviral treatments to fight Covid-19 will make the disease significantly more manageable and ensure the hospital system can easily cope with any future spike in post-lockdown cases.
-
Top honour for leading infectious diseases physician
Professor Josh Davis has been awarded the 2021 Frank Fenner Award for Advanced Research in Infectious Diseases.
-
.PNG&w=127&h=117)
Leading infectious diseases physician honoured with Frank Fenner Award
Professor Josh Davis has been awarded the 2021 Frank Fenner Award for Advanced Research in Infectious Diseases.
-
.jpg&w=127&h=117)
Tapeworm, vertigo and pancreatitis drugs are being trialled as COVID-19 treatments
Infectious diseases physician Professor Josh Davis from the Menzies School of Health Research is looking at whether a drug used to treat pancreatitis can be repurposed to treat COVID-19.
-
CDU academics named among world’s most influential
Menzies School of Health Research Professor Bart Currie, Professor Anne Chang AM, Professor Ric Price, Associate Professor Steven Tong, Professor Nicholas Anstey, Professor Joshua Davis, Professor Alan Cass, Professor Peter Morris and Professor Amanda Leach
-
NEWS Navigating COVID-19 ‘tiger country’
Catch up with Professor Josh Davis. An Infectious Diseases physician at Newcastle’s John Hunter Hospital and researcher at Menzies School of Health Research
-
CoronaCheck #32: Clive Palmer's 'ridiculous' hepatitis B comparison
Professor Josh Davis, a senior principal research fellow at Menzies and former president of ASID, told Fact Check that comparing deaths from hepatitis B and COVID-19 was "ridiculous".
-
Major research papers retracted over data controversy
Health Report on ABC Radio National - Scientists have raised concerns about the data underlying a number of major coronavirus research papers, causing two of the world's biggest medical journals.
-
An open letter from 119 scientists and researchers to The Lancet
Signed by clinicians, medical researchers, statisticians, and ethicists from across the world, follows the publication of a paper on using hydroxychloroquine or chloroquine for the treatment of COVID-19.
-
Innovative data use an important step in eliminating hep B
A team of researchers in the Northern Territory (NT) have designed and tested a new algorithm to determine hepatitis B status.
-
Q&A with infectious diseases expert Professor Josh Davis
Professor Josh Davis is a clinician researcher, and divides his time between clinical work as an infectious diseases physician in Newcastle, and research work as a senior principal research fellow based at Menzies. He is also the President of the...
-
Coronavirus assistance to Pacific and Timor-Leste
Coronavirus [COVID-19] is now affecting 75 countries, with the total number of cases over 90,000 and the global death toll at more than 3000.
-
Coronavirus assistance to Pacific and Timor-Leste
Coronavirus [COVID-19] is now affecting 75 countries, with the total number of cases over 90,000 and the global death toll at more than 3000.
-
CAMERA2: Standard MRSA treatment does not outperform combination therapy
Standard treatment for Methicillin-resistant Staphylococcus aureus (MRSA) infection is not more efficacious than combination therapy, according to new research published in JAMA.
-
Trial shows using two drugs not better than one when treating MRSA blood infections
Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects.
-
Trial shows using two drugs not better than one when treating MRSA blood infections
Researchers of methicillin-resistant Staphylococcus aureus (MRSA) blood infections say combination of two antibiotics was no better than one.
-
Study supports minimal monitoring in Sofosbuvir-based therapy for HCV
Some patients receiving sofosbuvir-based therapy for hepatitis C virus (HCV) may not need standard monitoring with clinic visits and blood testing.
-
PhD Expression of Interest | Camera 2 Study
We are looking for EOI for an ID / microbiology fellow to conduct follow-on studies from CAMERA2 as part of a PhD.
-
ASID Annual Scientific Meeting deemed a success for NT
The Australasian Society for Infectious Diseases (ASID) Annual Scientific Meeting 2019, held from 16–18 May, saw 450 attendees descend on the Darwin Convention Centre.
-
Combination Therapy for MRSA Bloodstream Infections: Still a Question Mark
In an editorial by Thomas Holland, at Duke University School of Medicine, and Prof Joshua Davis, at Menzies highlighted the significance of the new study’s findings in the larger context.
-
The winner takes it all for S. aureus
The CAMERA2 study, executed in multiple countries addressing the question whether addition of a beta-lactam antibiotic (7 days) improves outcome in patients with MRSA bacteremia.
-
Two New Trials of Combination Therapy for MRSA Bacteremia
The CAMERA2 study, just presented by Steven Tong at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
-
Hepatitis B DNA Helps Trace History and Movement of First Australians
The team found that hepatitis B virus isolated from these Aboriginal Australians is a unique strain called HBV/C4, which is not found anywhere else in the world.
-
Hepatitis B virus sheds light on ancient human population movements into Australia
Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia, adding weight to the theory that the mainland Aboriginal population separated from other early humans at least 59 thousand years ago and possibly entered the country near the Tiwi Islands.
-
Menzies researcher gains national recognition
Menzies Professor Josh Davis has been awarded a Research Excellence Award at the NHMRC annual awards dinner in Canberra.
-
Uptake of revolutionary hepatitis drugs lowest in areas of greatest need | ABC AM
The Northern Territory has the highest rate of hepatitis C in the country. But research by the Doherty Institute shows it has the second lowest rate of uptake of drugs that cure the disease.
-
Combination Therapy in Treating S. aureus Infections
Prof. Josh Davis, MBBS, PhD, Principle Research Fellow, Menzies School of Health Research, Australia, discusses the role of combination therapy when it comes to treating invasive Staphylococcus aureus infections.
-
RISE OF ANTIMICROBIAL RESISTANCE “DEEPLY ALARMING”
THE death of an American woman from an untreatable infection with a gram-negative bacterium resistant to all classes of antibiotics has left Australian infectious diseases experts “deeply alarmed”, according to an editorial published in the Medical Journal of Australia.
-
MJA Podcast on the clinical experience of patients with hepatitis C virus infection.
Associate Professor Joshua Davis is a Principal Research Fellow with the Menzies School of Health Research. He is the coauthor of a Short Report on the clinical experience of patients with hepatitis C virus infection among Australian GP trainees.
-
Drug-Resistant Golden Staph Breakthrough Tested By Volunteer Australian Doctors
When strains of the potentially deadly golden staph bacteria stopped responding to antibiotics in the 1960s, doctors scrambled to find a solution.
-
Defeating serious MRSA infections using an everyday drug that shouldn’t work
A new drug combination is the first step towards improving treatment of drug resistant golden staph (MRSA) - a breakthrough that could potentially save hundreds of lives, every day.
-
Infectious diseases specialist awarded $75 000 to continue fight against super-bug.
The grant will provide vital funding to develop trials in the areas of Staphylococcus aureus (golden Staph) infections, bone and joint infections and skin infections.
-
NHMRC career fellowship: Dr Josh Davis
Menzies infectious diseases specialist, Dr Josh Davis was recently awarded a Career Development Fellowship as part of the National Health and Medical Research Council’s (NHMRC) yearly multi-million dollar funding round. Josh’s fellowship...
-
NHMRC project snapshot: Dr Josh Davis
Menzies infectious diseases specialist, Dr Josh Davis was recently awarded a competitive project grant as part of the National Health and Medical Research Council’s (NHMRC) yearly multi-million dollar funding round.
-
NHMRC project snapshot: Dr Steve Tong
Menzies' Post-doctoral Research Fellow Dr Steve Tong was recently awarded a competitive grant and a fellowship as part of the National Health and Medical Research Council's yearly multi-million dollar funding round.